D.R. Lazăr, A.D. Farcas, C. Blag, et. al.
CARDIONCOLOGY.ORG ABSTRACT:
This review summarizes the research related to anthracycline-induced cardiac toxicity in children treated for leukemia. The authors conclude that early and systematic evaluation is essential to avoid progressive heart failure following anthracycline associated cardiomyocyte loss.
The authors further suggest that in addition to echocardiographic assessment of left ventricle ejection fraction and cardiac biomarker evaluation to monitor cardiac function, cancer patients require follow-up and treatment to ensure good quality of life.
© All Rights Reserved